NCT00091741View on ClinicalTrials.gov

Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2004

Conditions

HIV Infection

Interventions

DRUG

Etanercept (Enbrel)

Trial Locations (1)

20057

Georgetown University Medical Center, Washington D.C.

Sponsors

Collaborators (1)

Advanced Biotherapy, Inc.

All Listed Sponsors

collaborator

Advanced Biotherapy, Inc.

INDUSTRY

lead

Georgetown University

OTHER

NCT00091741 - Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects | Biotech Hunter | Biotech Hunter